Members of Congress are not small-time traders. Some of the wealthiest individuals in American politics hold investment portfolios worth tens of millions of dollars and execute trades that would be considered significant by any standard. This article examines the biggest congressional stock trades by dollar amount, the most consequential trades by timing and outcome, and the most controversial trades that have drawn public scrutiny. You can explore the latest trading data in real time on the CongressFlow trades page.
Understanding the Disclosure System: Why We Use Ranges
Before examining specific trades, it is important to understand a fundamental limitation of congressional financial disclosure data. Unlike corporate insiders, who must report exact share quantities and prices on SEC Form 4 filings, members of Congress report their trades using broad dollar ranges. A trade reported in the "$1,000,001 to $5,000,000" range could be worth $1.1 million or $4.9 million — a nearly fivefold difference.
This range-based system was established when disclosure requirements were first created and has never been updated despite repeated calls for reform. It means that any ranking of "biggest trades" necessarily involves estimates and ranges rather than precise figures. When we refer to the "largest" trades, we mean those disclosed in the highest reporting ranges, which indicate trades valued at $5 million, $25 million, or even $50 million and above.
The Largest Trades by Dollar Amount
Several members of Congress have consistently traded at the highest reporting tiers, disclosing transactions worth millions of dollars in individual stocks.
Paul Pelosi (spouse of former Speaker Nancy Pelosi): The Pelosi household has been the most scrutinized in congressional trading. Paul Pelosi has disclosed numerous trades in the $1,000,001–$5,000,000 and $250,001–$500,000 ranges, including significant positions in technology companies like Apple, NVIDIA, Alphabet (Google), Microsoft, Amazon, and Salesforce. His call option purchases in technology stocks, particularly ahead of major legislative activity affecting the tech sector, have generated intense public and media attention. For a detailed analysis, see our article on Pelosi trading.
Senator Mark Warner (D-VA): One of the wealthiest members of Congress, Warner has disclosed trades in the highest reporting ranges across multiple sectors. As a former technology executive and venture capitalist, his portfolio is heavily weighted toward technology and financial services. His trades have included multi-million-dollar positions in companies directly relevant to his committee work on the Senate Intelligence and Banking committees.
Representative Michael McCaul (R-TX): McCaul, who has served as Chairman of the House Foreign Affairs Committee, has consistently been among the wealthiest members of Congress with a portfolio valued in excess of $100 million (primarily through his wife's family wealth). His disclosures include some of the largest trades in congressional filings, spanning technology, financial services, and industrial sectors.
Representative Ro Khanna (D-CA): Khanna has disclosed significant trades in technology stocks, consistent with his representation of a Silicon Valley district. His trades in semiconductor and software companies have been among the larger positions reported by House members.
The Most Consequential Trades: Best Timing and Biggest Returns
The most consequential congressional trades are not necessarily the largest by dollar amount but rather those with the most striking timing relative to market-moving events. These trades generated the best returns and, in some cases, the most suspicion.
Pre-COVID sell-offs (January–February 2020): The most consequential cluster of congressional trades in recent history occurred in January and February 2020, when several senators sold significant stock positions after receiving classified briefings on the emerging COVID-19 pandemic but before the market crash in late February and March. Senator Richard Burr (R-NC), then chairman of the Senate Intelligence Committee, sold between $628,000 and $1.72 million in stock holdings on February 13, 2020 — dumping his holdings in hotel and travel companies just days after attending a classified briefing on the virus. Senator Kelly Loeffler (R-GA) and her husband disclosed sales of millions of dollars in stock on the same day they attended a Senate Health Committee briefing on COVID-19. Both Burr and Loeffler faced DOJ and SEC investigations, though neither was ultimately charged.
NVIDIA trades ahead of the AI boom: Multiple members of Congress purchased NVIDIA stock in 2022 and 2023, ahead of the company's extraordinary surge driven by artificial intelligence demand. While NVIDIA was a popular stock among retail investors as well, the timing of certain congressional purchases — particularly by members with access to briefings on AI policy and semiconductor legislation including the CHIPS and Science Act — drew scrutiny. Members who purchased NVIDIA before the CHIPS Act vote in July 2022 saw particularly strong returns.
Defense stock purchases before appropriations: Trades in defense contractors like Lockheed Martin, Raytheon (now RTX), Northrop Grumman, and General Dynamics by members serving on the Armed Services and Appropriations committees have been among the most scrutinized. The timing of these purchases relative to defense appropriations votes, contract announcements, and geopolitical events (particularly the Russian invasion of Ukraine in February 2022) has raised questions about whether committee members traded on advance knowledge of defense spending decisions.
The Most Controversial Trades: Scrutiny and Scandal
Some congressional trades have become controversial not because of their size or returns but because of the circumstances surrounding them.
Pharmaceutical trades by Health Committee members: Members of the Senate Health, Education, Labor, and Pensions (HELP) Committee and the House Energy and Commerce Committee have disclosed trades in pharmaceutical companies whose products, pricing, and regulations are directly affected by their committee work. Trades in companies like Pfizer, Moderna, Johnson & Johnson, and AbbVie by members with oversight of drug pricing legislation and FDA policy have drawn persistent criticism.
Energy sector trades during policy debates: Trades in oil, gas, and renewable energy companies by members of the Senate Energy and Natural Resources Committee and the House Energy and Commerce Committee have been scrutinized during periods of active energy legislation. Members who traded in fossil fuel companies while voting on climate legislation or in renewable energy companies while voting on clean energy subsidies have faced allegations of conflicts of interest.
Financial sector trades by Banking Committee members: Members of the Senate Banking Committee and House Financial Services Committee who trade in bank stocks, insurance companies, and financial services firms face obvious potential conflicts, given that these committees directly regulate the financial industry. Trades during periods of active banking regulation, particularly around the regional banking crisis of March 2023, attracted significant attention.
Most Traded Stocks: What Congress Buys Most Often
Looking at the aggregate data, certain stocks appear repeatedly in congressional disclosure filings. The most traded stocks in Congress are dominated by large-cap technology and defense companies.
Technology: Apple (AAPL), Microsoft (MSFT), NVIDIA (NVDA), Alphabet (GOOGL), Amazon (AMZN), and Meta (META) are among the most frequently traded stocks by members of Congress. This partly reflects the dominance of these companies in the broader stock market but also reflects the fact that technology policy — including antitrust regulation, AI policy, data privacy, and semiconductor manufacturing — is a major area of congressional activity.
Defense: Lockheed Martin (LMT), Raytheon/RTX (RTX), Northrop Grumman (NOC), General Dynamics (GD), and L3Harris Technologies (LHX) appear frequently, particularly among members of the Armed Services and Appropriations committees.
Pharmaceuticals and healthcare: Pfizer (PFE), Johnson & Johnson (JNJ), UnitedHealth Group (UNH), AbbVie (ABBV), and various biotech companies appear regularly in congressional filings, particularly from members on health-related committees.
Financial services: JPMorgan Chase (JPM), Goldman Sachs (GS), Bank of America (BAC), and other major financial institutions are frequently traded by members with ties to financial oversight committees.
What the Data Reveals About Congressional Trading Patterns
Examining the biggest congressional trades as a whole reveals several patterns. First, congressional trading is heavily concentrated among a relatively small number of very active traders. Most members of Congress trade infrequently or not at all in individual stocks, while a small cohort trades actively and in large amounts. Second, the most traded stocks tend to be large-cap companies in sectors that Congress directly regulates, creating persistent potential conflicts of interest.
Third, the most controversial trades are not always the largest. A $15,000 trade by a committee chair in a company with a pending matter before the committee may be far more troubling than a $5 million trade by a wealthy member in a blue-chip stock unrelated to their policy responsibilities. Size alone is not the best indicator of potential conflict — context, timing, and committee jurisdiction matter more.
To track the latest congressional trades in real time, visit the CongressFlow trades page. To see which members are generating the highest returns, check the leaderboard. And for the historical context of congressional trading scandals, read our analysis of the Pelosi trading controversy.
